BSE filing, BSE: 544823. Summary written from the filing by ALFA Finder's alert engine.
Devson Catalyst Ltd: key numbers
- Share price
- ₹355.00
- Market cap
- ₹482.4 Cr
- Revenue (annual)
- ₹55.78 Cr
- Net profit (annual)
- ₹12.52 Cr
- P/E (TTM)
- 38.5×Sector 34.5×
- Promoter holding
- 73.59%
- FII holding
- 1.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Devson Catalyst Ltd
All →Devson Catalyst Board Meeting Date
Devson Catalyst Ltd scheduled its board for November 2, 2026, to approve H1 FY27 unaudited standalone results. No monetary value disclosed in this intimation.
Devson Catalyst Annual General Meeting
Devson Catalyst Limited held its 22nd Annual General Meeting on September 29, 2026, through video conferencing. The meeting covered adoption of financial statements and routine business resolutions.
Devson Catalyst Other Announcement
Devson Catalyst Ltd informed the exchange of a name change for its Secretarial Auditor, M/s. ALAP & Co. LLP to M/s. Prasad and Partners LLP. The appointment's terms remain unchanged.
Devson Catalyst Annual General Meeting
Devson Catalyst Limited issued a notice for its 22nd Annual General Meeting on September 29, 2026, via VC/OAVM. The agenda includes ordinary and special business.
Devson Catalyst Annual Report
Devson Catalyst Limited has submitted its Annual Report for the financial year 2025-26, fulfilling regulatory compliance requirements under SEBI (LODR) Regulations.
Devson Catalyst Business Update
Devson Catalyst announced the successful development of its Ammonia Decomposition Catalyst and confirmed receiving new commercial orders from Tata Steel and NMDC.
- From
- Tata Steel and NMDC
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.